<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cellectis S.A.

    Cellectis S.A.

    Cellectis is a clinical-stage biopharmaceutical company that harnesses the immune ...

    Cellectis is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    DURECT Corporation

    DURECT Corporation

    DURECT is a biopharmaceutical company actively developing therapeutics based on it...

    DURECT is a biopharmaceutical company actively ...

    Filing Type:    PU
    Karyopharm Therapeutics Inc.

    Karyopharm Therapeutics Inc.

    Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on ...

    Karyopharm Therapeutics is an innovation-driven...

    Filing Type:    PU
    China Biologic Products Holdings, Inc.

    China Biologic Products Holdings, Inc.

    China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrat...

    China Biologic Products Holdings, Inc. (NASDAQ:...

    Filing Type:    PU
    Nature's Sunshine Products, Inc.

    Nature's Sunshine Products, Inc.

    Nature’s Sunshine Products (NASDAQ:NATR), a leading natural health and wellness ...

    Nature’s Sunshine Products (NASDAQ:NATR), a l...

    Filing Type:    PU
    Novartis AG

    Novartis AG

    Novartis is reimagining medicine to improve and extend people’s lives. As a leadin...

    Novartis is reimagining medicine to improve and...

    Filing Type:    PU
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Precipio, Inc.

    Precipio, Inc.

    Precipio has built a platform designed to eradicate the problem of misdiagnosis by...

    Precipio has built a platform designed to eradi...

    Filing Type:    PU
    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.